Cargando…
Cardiovascular and musculskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency
BACKGROUND: Determining the presence and extent of co-morbidities is fundamental in assessing patients with chronic respiratory disease, where increased cardiovascular risk, presence of osteoporosis and low muscle mass have been recognised in several disease states. We hypothesised that the systemic...
Autores principales: | Duckers, James M, Shale, Dennis J, Stockley, Robert A, Gale, Nichola S, Evans, Bronwen AJ, Cockcroft, John R, Bolton, Charlotte E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004850/ https://www.ncbi.nlm.nih.gov/pubmed/21138571 http://dx.doi.org/10.1186/1465-9921-11-173 |
Ejemplares similares
-
Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?
por: Gale, Nichola S, et al.
Publicado: (2011) -
Alpha-1 Antitrypsin Deficiency: The Learning Goes On
por: Stockley, Robert. A.
Publicado: (2020) -
Low bone mineral density in men with chronic obstructive pulmonary disease
por: Duckers, James M, et al.
Publicado: (2011) -
Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
por: Belchamber, Kylie B R, et al.
Publicado: (2020) -
Improving the Lives of Patients with Alpha-1 Antitrypsin Deficiency
por: Sandhaus, Robert A, et al.
Publicado: (2020)